Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib. Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR).
创建时间：
2016-09-06
